Mechanistic Insight into Copper-Mediated Trifluoromethylation of Aryl Halides: The Role of CuI was written by Liu, He;Wu, Jian;Jin, Yuxuan;Leng, Xuebing;Shen, Qilong. And the article was included in Journal of the American Chemical Society in 2021.Quality Control of Ethyl 3-chloroquinoxaline-2-carboxylate This article mentions the following:
The synthesis, characterization, and reactivity of key intermediates [Cu(CF3)(X)]–Q+ (X = CF3 or I, Q = PPh4) in copper-mediated trifluoromethylation of aryl halides were studied. Qual. and quant. studies showed [Cu(CF3)2]–Q+ and [Cu(CF3)(I)]–Q+ were not highly reactive. Instead, a much more reactive species, ligand-less [CuCF3] or DMF-ligated species [(DMF)CuCF3], was generated in the presence of excess CuI. On the basis of these results, a general mechanistic map for CuI-promoted trifluoromethylation of aryl halides was proposed. Furthermore, on the basis of this mechanistic understanding, a HOAc-promoted protocol for trifluoromethylation of aryl halides with [Ph4P]+[Cu(CF3)2]– was developed. In the experiment, the researchers used many compounds, for example, Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0Quality Control of Ethyl 3-chloroquinoxaline-2-carboxylate).
Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Quinoxalines are important class of heterocyclic compounds, associated with wider pharmacological applications. Quinoxalines are used in the treatment of bacterial, cancer, and HIV infections. Moreover, varenicline, a clinical drug is used for treating nicotine addiction, also contains quinoxaline moiety.Quality Control of Ethyl 3-chloroquinoxaline-2-carboxylate
Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider